FREDERICK, Md., May 27, 2020 /PRNewswire/ — Amivas (US), LLC, specialists in treatments for rare and neglected tropical diseases, including severe malaria, announced today that Artesunate for Injection 110 mg, powder and solvent for solution has…Original Article
You may also like
FDA Approves Orlynvah (sulopenem etzadroxil and...
U.S. FDA Approves Pfizer’s RSV Vaccine Abrysvo for...
Alvotech and Teva Announce U.S. FDA Approval of...
FDA Approves Vyloy (zolbetuximab-clzb) for the...
Botox Cosmetic (onabotulinumtoxinA) Receives FDA...
FDA Approves Vyalev (foscarbidopa and foslevodopa) for...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.